JP2005518379A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518379A5
JP2005518379A5 JP2003552769A JP2003552769A JP2005518379A5 JP 2005518379 A5 JP2005518379 A5 JP 2005518379A5 JP 2003552769 A JP2003552769 A JP 2003552769A JP 2003552769 A JP2003552769 A JP 2003552769A JP 2005518379 A5 JP2005518379 A5 JP 2005518379A5
Authority
JP
Japan
Prior art keywords
aryl
heteroaryl
lower alkyl
group
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003552769A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518379A (ja
Filing date
Publication date
Priority claimed from DE10161940A external-priority patent/DE10161940A1/de
Application filed filed Critical
Publication of JP2005518379A publication Critical patent/JP2005518379A/ja
Publication of JP2005518379A5 publication Critical patent/JP2005518379A5/ja
Pending legal-status Critical Current

Links

JP2003552769A 2001-12-17 2002-12-04 プロテインキナーゼ阻害剤としてのn−炭素環式単置換インドロカルバゾール Pending JP2005518379A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10161940A DE10161940A1 (de) 2001-12-17 2001-12-17 N-Carbacyclus-monosubstitutierte Indolocarbazole als Proteinkinase-inhibitoren
PCT/EP2002/013753 WO2003051887A1 (en) 2001-12-17 2002-12-04 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2005518379A JP2005518379A (ja) 2005-06-23
JP2005518379A5 true JP2005518379A5 (cg-RX-API-DMAC10.html) 2006-01-26

Family

ID=7709523

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003552769A Pending JP2005518379A (ja) 2001-12-17 2002-12-04 プロテインキナーゼ阻害剤としてのn−炭素環式単置換インドロカルバゾール

Country Status (7)

Country Link
US (1) US7262215B2 (cg-RX-API-DMAC10.html)
EP (1) EP1456211A1 (cg-RX-API-DMAC10.html)
JP (1) JP2005518379A (cg-RX-API-DMAC10.html)
AU (1) AU2002356625A1 (cg-RX-API-DMAC10.html)
CA (1) CA2467780A1 (cg-RX-API-DMAC10.html)
DE (1) DE10161940A1 (cg-RX-API-DMAC10.html)
WO (1) WO2003051887A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122526B2 (en) * 2000-10-31 2006-10-17 Nanosphere, Inc. Indolocarbazole anticancer agents and methods of using same
CL2007003693A1 (es) 2006-12-22 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
US20100273769A1 (en) * 2009-01-26 2010-10-28 Hanno Roder Composition and method for the treatment of parkinson's disease
CN102557967A (zh) * 2011-12-28 2012-07-11 合肥科尚医药科技有限公司 一种盐酸氨溴索的制备方法
CN103113379A (zh) * 2013-03-12 2013-05-22 盛世泰科生物医药技术(苏州)有限公司 阿塞那平马来酸盐的合成工艺
CN117886799B (zh) * 2024-01-11 2025-07-29 浙江工业大学 一类靶向降解GSK-3β的蛋白降解靶向嵌合体化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5438050A (en) * 1988-02-06 1995-08-01 Godecke Aktiengesellschaft Indolocarbazole derivatives, processes for their preparation and compositions containing them
ATE175873T1 (de) * 1992-03-20 1999-02-15 Wellcome Found Weitere indolderivate mit antiviraler wirkung
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
GB9416467D0 (en) * 1994-08-13 1994-10-05 Wellcome Found Compounds for use in medicine
CN1285836A (zh) * 1997-12-31 2001-02-28 赛福伦公司 3′-差向异构的K-252a衍生物
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
US7122526B2 (en) * 2000-10-31 2006-10-17 Nanosphere, Inc. Indolocarbazole anticancer agents and methods of using same
WO2003022861A1 (en) * 2001-09-13 2003-03-20 Bristol-Myers Squibb Company Process for the preparation of rebeccamycin and analogs thereof

Similar Documents

Publication Publication Date Title
CA2671071A1 (en) Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
JP2005523310A5 (cg-RX-API-DMAC10.html)
WO2005021584A3 (en) Novel peptidomimetic ns3-serine protease inhibitors of hepatitis c virus
JP2007516206A5 (cg-RX-API-DMAC10.html)
JP2010535722A5 (cg-RX-API-DMAC10.html)
JP2010501478A5 (cg-RX-API-DMAC10.html)
JP2008510828A5 (cg-RX-API-DMAC10.html)
JP2008503515A5 (cg-RX-API-DMAC10.html)
CA2356263A1 (en) Aminopyrazole derivatives
HUP0302002A2 (hu) A glikogén-szintáz-kináz (GSK-3) heterociklusos inhibitorai, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
CA2671127A1 (en) Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
JP2006514691A5 (cg-RX-API-DMAC10.html)
WO2008060476A3 (en) Nitrogen-containing heterocyclic compounds and methods of use thereof
WO2002032874A8 (en) Substituted heterocyclic compounds for treating multidrug resistance
CA2534024A1 (en) Novel compounds having inhibitory activity against sodium-dependant transporter
JP2010511721A5 (cg-RX-API-DMAC10.html)
AU2001230564A1 (en) Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
JP2009543867A5 (cg-RX-API-DMAC10.html)
CY2014004I2 (el) Χρηση (ζ)-2-κυανο-3-υδροξυ-βουτ-2-ενοικου οξεος-(4΄-τριφθορομεθυλοφαινυλο)-αμιδης για τη θεραπεια της πολλαπλης σκληρωσης
WO2003076398A3 (en) Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors
EA200701233A1 (ru) Производные хиназолина в качестве mtki
JP2003221386A5 (cg-RX-API-DMAC10.html)
MY138826A (en) 2,7-substituted indoles
WO2009041559A1 (ja) インダゾールアクリル酸アミド化合物
WO2004046107A8 (en) Indole derivatives as somatostatin agonists or antagonists